Euclidean Capital LLC 13F Holdings · Q2 2026
Euclidean Capital LLC reported 11 securities worth $439.84M in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: VEU (61.76%), VTV (25.76%), INDA (4.15%). Among its top 25 positions this quarter: 1 new.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | VEU | VANGUARD INTL EQUITY INDEX F | $271.6M | 61.76% | 3.2M | Hold |
| 2 | VTV | VANGUARD INDEX FDS | $113.3M | 25.76% | 520,000 | Hold |
| 3 | INDA | ISHARES TR | $18.3M | 4.15% | 369,600 | Hold |
| 4 | ORIC | ORIC PHARMACEUTICALS INC | $10.7M | 2.44% | 989,410 | Hold |
| 5 | TMS | TEAMSHARES INC | $9.0M | 2.06% | 1.1M | New |
| 6 | FHTX | FOGHORN THERAPEUTICS INC | $7.7M | 1.75% | 1.6M | Hold |
| 7 | PMVP | PMV PHARMACEUTICALS INC | $3.5M | 0.80% | 2.6M | Hold |
| 8 | ALEC | ALECTOR INC | $2.6M | 0.60% | 1.3M | Hold |
| 9 | SRZN | SURROZEN INC | $2.3M | 0.52% | 87,696 | Hold |
| 10 | TNYA | TENAYA THERAPEUTICS INC | $750,708 | 0.17% | 1.0M | Hold |
| 11 | SRZNW | SURROZEN INC | $2,819 | 0.00% | 170,833 | Hold |
Source: SEC Form 13F filings · as of 2026-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR